We see all our donors as part of the Leukaemia UK family and we keep them informed of our progress. As a valued supporter, you will have the level of contact and involvement which suits you, whether that means reporting, updates on progress, or meeting the team and trustees, if you wish.

We understand you want to achieve the best impact for your investment, one which suits your own interests and has a significant impact on accelerating life-changing leukaemia research.

The incredible funding from trusts and foundations has been integral to the development of Leukaemia UK’s work over many years.

Not only are trust and foundations enabling our talented researchers to harness the power of science to gain a better knowledge and understanding of leukaemia, they have also been crucial in enabling researchers to use this learning to leverage out next stage funding to begin to accelerate the development of smarter, kinder therapies for leukaemia.

Research has to power to change lives and we are establishing a Patient Advisory Panel, led by people living with leukaemia. This helps us to prioritise the research that matters most, helping improve the patient experience, from diagnosis to treatment and care.

We are expanding our research programme including investing further in the leukaemia research leaders of today and tomorrow, project grants to tackle the big questions, collaboration grants to go further, faster – and applied research, to ensure breakthroughs reach patients sooner.

In 2021/22 we were proud to announce, Dr Pramila Krishnamurthy of King’s College Hospital and King’s College London as the Leukaemia UK John Goldman Fellow co-funded by Rosetrees Trust.

Dr Krishnamurthy is using the fellowship to better understand why some leukaemia patients relapse following a stem cell transplant, and how donor lymphocyte infusion can help prevent this.